Key facts
- It has raised $16.7M; the latest was Later Stage VC in Aug 2025.
- Notable investors include Zhuhai High-tech Financial Investment, China Merchants Securities Capital, CDBI Partners, Midas Capital (China), Sunland Fund — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Pulse Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Pulse Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pulse Medical
Manufacturer of cardiovascular medical devices designed for use in hospitals to use treat patients with chronic cardiovascular disease. The company's products include external shock wave therapy for heart, aurcle occluder system, and heart parachute, enabling doctors and medical surgeons to treat patients with heart failure and diseases efficiently and in a timely manner.
- Sector
- Healthcare
- HQ
- Zhuhai, China
- Founded
- 2014
- Employees
- 15
- Website
- pulsemed.cn/
- Ownership
- Privately Held (backing)
Pulse Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pulse Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pulse Medical in its N-PORT filings yet. We sweep new filings monthly.